Hepion Pharmaceuticals, Inc. (HEPA)
0.066
-0.01
(-7.11%)
USD |
OTCM |
Sep 03, 16:00
Hepion Pharmaceuticals Total Assets (Quarterly) : 1.927M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.927M |
| March 31, 2026 | 2.706M |
| December 31, 2025 | 3.07M |
| September 30, 2025 | 3.740M |
| June 30, 2025 | 4.506M |
| March 31, 2025 | 6.319M |
| December 31, 2024 | 1.614M |
| September 30, 2024 | 3.715M |
| June 30, 2024 | 6.010M |
| March 31, 2024 | 15.99M |
| December 31, 2023 | 18.16M |
| September 30, 2023 | 25.00M |
| June 30, 2023 | 36.50M |
| March 31, 2023 | 49.50M |
| December 31, 2022 | 60.81M |
| September 30, 2022 | 69.70M |
| June 30, 2022 | 83.57M |
| March 31, 2022 | 95.86M |
| December 31, 2021 | 104.17M |
| September 30, 2021 | 111.60M |
| June 30, 2021 | 119.75M |
| March 31, 2021 | 123.76M |
| December 31, 2020 | 49.38M |
| September 30, 2020 | 20.36M |
| June 30, 2020 | 24.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 23.27M |
| December 31, 2019 | 20.43M |
| September 30, 2019 | 21.07M |
| June 30, 2019 | 23.34M |
| March 31, 2019 | 7.904M |
| December 31, 2018 | 8.189M |
| September 30, 2018 | 14.38M |
| June 30, 2018 | 7.975M |
| March 31, 2018 | 9.396M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 13.11M |
| March 31, 2016 | 6.750M |
| December 31, 2015 | 10.65M |
| September 30, 2015 | 2.854M |
| June 30, 2015 | 5.377M |
| March 31, 2015 | 9.500M |
| December 31, 2014 | 8.965M |
| September 30, 2014 | 1.005M |
| June 30, 2014 | 2.001M |
| March 31, 2014 | 2.644M |
| December 31, 2013 | 0.0088M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6489M |
| Shareholders Equity (Quarterly) | 1.278M |
| Current Ratio | 3.911 |
| Net Debt Paydown Yield | 5.33% |